fracture risk in older dlbcl patients after r-chop
Published 4 years ago • 534 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
6:12
coalition: glofitamab r-chop or glofitamab pola-r-chp in patients with high-risk dlbcl
-
2:15
frontmind: tafasitamab lenalidomide r-chop vs r-chop for newly diagnosed high-risk dlbcl
-
1:57
r-chop dose intensity and survival outcomes in dlbcl
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
1:12
smart stop: moving away from r-chop in dlbcl
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
2:13
phase ii trial of split-dose r-chop for older patients with dlbcl
-
1:51
10-year follow-up of the lnh03-6b trial: outcomes of older patients with dlbcl treated with r-chop
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
1:45
improving the frontline treatment of dlbcl
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
5:45
insights into the remodl-a trial: acalabrutinib plus r-chop for patients with dlbcl
-
2:03
novel treatment approaches for early-stage dlbcl
-
3:58
phase ib/iia study of azd4573 acalabrutinib in r/r dlbcl
-
1:23
phoenix: ibrutinib in combination with r-chop for dlbcl
-
1:44
remodl-b: bortezomib r-chop versus r-chop in patients with dlbcl
-
3:39
the role of novel therapies in r/r dlbcl
-
4:01
first- and second-line treatment in dlbcl
-
2:55
ibrutinib in combination with r-chop in dlbcl: does age make a difference?
-
1:11
evaluating salvage radiotherapy in patients with dlbcl